Home Tags Dupilumab
The antibody drug was approved for use in the U,S. last March.
The antibody drug will be marketed as Dupixent and available to adults with moderate to severe atopic dermatitis .
Dupixent will go on the U.S. market this week as the first antibody medicine for uncontrolled itching and rashes in adults with atopic dermatitis.